97
Views
1
CrossRef citations to date
0
Altmetric
Research Articles

Evaluation of GHK peptide–heparin interactions in multifunctional liposomal covering

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 18-30 | Received 26 Nov 2022, Accepted 12 Jan 2023, Published online: 05 May 2023

References

  • Accardo, A., and Morelli, G., 2015. Review peptide-targeted liposomes for selective drug delivery: advantages and problematic issues. Biopolymers, 104 (5), 462–479.
  • Amand, H.L., et al., 2012. Cell surface binding and uptake of arginine- and lysine-rich penetratin peptides in absence and presence of proteoglycans. Biochimica et biophysica acta, 1818 (11), 2669–2678.
  • Andrade, S., et al., 2021. Liposomes as biomembrane models: biophysical techniques for drug-membrane interaction studies. Journal of molecular liquids, 334, 116141.
  • Arul, V., et al., 2005. Biotinylated GHK peptide incorporated collagenous matrix: a novel biomaterial for dermal wound healing in rats. Journal of biomedical materials research, 73 (2), 383–391.
  • Beretta, G., et al., 2007. Glycyl-histidyl-lysine (GHK) is a quencher of α,β-4-hydroxy-trans-2-nonenal: a comparison with carnosine. Insights into the mechanism of reaction by electrospray ionization mass spectrometry, 1H NMR, and computational techniques. Chemical research in toxicology, 20 (9), 1309–1314.
  • Beretta, G., et al., 2008. Acrolein sequestering ability of the endogenous tripeptide glycyl-histidyl-lysine (GHK): characterization of conjugation products by ESI-MSn and theoretical calculations. Journal of pharmaceutical and biomedical analysis, 47 (3), 596–602.
  • Broggini, N., et al., 2012. Evaluation of chemically modified SLA implants (modSLA) biofunctionalized with integrin (RGD)- and heparin (KRSR)-binding peptides. Journal of biomedical materials research, 100 (3), 703–711.
  • Chen, C., et al., 2017. Peptide-22 and cyclic RGD functionalized liposomes for glioma targeting drug delivery overcoming BBB and BBTB. ACS applied materials and interfaces, 9 (7), 5864–5873.
  • Chen, K., and Chen, X., 2011. Integrin targeted delivery of chemotherapeutics. Theranostics, 1, 189–200.
  • Chen, Y., et al., 2015. A low-molecular-weight heparin-coated doxorubicin-liposome for the prevention of melanoma metastasis. Journal of drug targeting, 23 (4), 335–346.
  • Cheng, Y., and Ji, Y., 2019. RGD-modified polymer and liposome nanovehicles: recent research progress for drug delivery in cancer therapeutics. European journal of pharmaceutical sciences, 128, 8–17.
  • Choi, H.R., et al., 2012. Stem cell recovering effect of copper-free GHK in skin. Journal of peptide science, 18 (11), 685–690.
  • Dao, D.T., et al., 2018. Heparin-binding epidermal growth factor – like growth factor as a critical mediator of tissue repair and regeneration. The American journal of pathology, 188 (11), 2446–2456.
  • Di Santo, M.C., et al., 2020. Biological responses induced by high molecular weight chitosan administrated jointly with platelet-derived growth factors in different mammalian cell lines. International journal of biological macromolecules, 158, 953–967.
  • Errante, F., et al., 2020. Cosmeceutical peptides in the framework of sustainable wellness economy. Frontiers in chemistry, 8, 572923.
  • Farkuh, L., et al., 2019. Characterization of phospholipid vesicles containing lauric acid: physicochemical basis for process and product development. Heliyon, 5 (10), e02648.
  • Filipczak, N., et al., 2020. Recent advancements in liposome technology. Advanced drug delivery reviews, 156, 4–22.
  • Fromm, J.R., et al., 1995. Differences in the interaction of heparin with arginine and lysine and the importance of these basic amino acids in the binding of heparin to acidic fibroblast growth factor. Archives of biochemistry and biophysics, 323 (2), 279–287.
  • Gomes, A., et al., 2017. Wound-healing peptides for treatment of chronic diabetic foot ulcers and other infected skin injuries. Molecules, 22 (10), 1743.
  • Han, H.D., et al., 2006. In vivo distribution and antitumor activity of heparin-stabilized doxorubicin-loaded liposomes. International journal of pharmaceutics, 313 (1–2), 181–188.
  • Høyrup, P., Davidsen, J., and Jørgensen, K., 2001. Lipid membrane partitioning of lysolipids and fatty acids: effects of membrane phase structure and detergent chain length. The journal of physical chemistry B, 105 (13), 2649–2657.
  • Huang, P.J., et al., 2007. In vitro observations on the influence of copper peptide aids for the LED photoirradiation of fibroblast collagen synthesis. Photomedicine and laser surgery, 25 (3), 183–190.
  • Hur, G.H., et al., 2020. Effect of oligoarginine conjugation on the antiwrinkle activity and transdermal delivery of GHK peptide. Journal of peptide science, 26, e3234.
  • Ishkaeva, R.A., et al., 2022. Probing cell redox state and glutathione-modulating factors using a monochlorobimane-based microplate assay. Antioxidants, 11 (2), 391.
  • Jia, J., et al., 2016. Development of peptide-functionalized synthetic hydrogel microarrays for stem cell and tissue engineering applications. Acta biomaterialia, 45, 110–120.
  • Jiang, Z., et al., 2019. Peptide ligand-mediated targeted drug delivery of nanomedicines. Biomaterials science, 7 (2), 461–471.
  • Joung, Y.K., Bae, J.W., and Park, K.D., 2008. Controlled release of heparin-binding growth factors using heparin-containing particulate systems for tissue regeneration. Expert opinion on drug delivery, 5 (11), 1173–1184.
  • Kang, Y.A., et al., 2009. Copper-GHK increases integrin expression and p63 positivity by keratinocytes. Archives of dermatological research, 301 (4), 301–306.
  • Kassaar, O., et al., 2015. Plasma free fatty acid levels influence Zn(2+) -dependent histidine-rich glycoprotein-heparin interactions via an allosteric switch on serum albumin. Journal of thrombosis and haemostasis, 13 (1), 101–110.
  • Khan, A.A., et al., 2020. Recent strategies towards the surface modification of liposomes: an innovative approach for different clinical applications. 3 biotech, 10 (4), 163.
  • Kluza, E., et al., 2012. Dual-targeting of alphavbeta3 and galectin-1 improves the specificity of paramagnetic/fluorescent liposomes to tumor endothelium in vivo. Journal of controlled release, 158 (2), 207–214.
  • Kowitsch, A., Zhou, G., and Groth, T., 2018. Medical application of glycosaminoglycans: a review. Journal of tissue engineering and regenerative medicine, 12 (1), e23–e41.
  • Kwon, S.-H., and Park, K.-C., 2020. Antioxidants as an epidermal stem cell activator. Antioxidants, 9 (10), 958.
  • Luong, T.D., et al., 2020. In situ functionalization of poly(hydroxyethyl methacrylate) cryogels with oligopeptides via beta-cyclodextrin-adamantane complexation for studying cell-instructive peptide environment. ACS applied bio materials, 3 (2), 1116–1128.
  • Marques, J., et al., 2014. Application of heparin as a dual agent with antimalarial and liposome targeting activities toward Plasmodium-infected red blood cells. Nanomedicine, 10 (8), 1719–1728.
  • Missirlis, D., et al., 2017. Fibronectin promotes directional persistence in fibroblast migration through interactions with both its cell-binding and heparin-binding domains. Scientific reports, 7 (1), 3711.
  • Mohamed, S., and Coombe, D.R., 2017. Heparin mimetics: their therapeutic potential. Pharmaceuticals, 10 (4), 78.
  • Monteiro, N., et al., 2014. Liposomes in tissue engineering and regenerative medicine. Journal of the royal society, interface, 11 (101), 20140459.
  • Moyano, J.V., et al., 2003. A synthetic peptide from the heparin-binding domain III (repeats III4-5) of fibronectin promotes stress-fibre and focal-adhesion formation in melanoma cells. The biochemical journal, 371 (Pt 2), 565–571.
  • Nguyen, K., and Rabenstein, D.L., 2016. Interaction of the heparin-binding consensus sequence of beta-amyloid peptides with heparin and heparin-derived oligosaccharides. The journal of physical chemistry B, 120 (9), 2187–2197.
  • Palomo, J.M., 2014. Solid-phase peptide synthesis: an overview focused on the preparation of biologically relevant peptides. RSC Advances, 4 (62), 32658–32672.
  • Park, J.R., et al., 2016. The tri-peptide GHK-Cu complex ameliorates lipopolysaccharide-induced acute lung injury in mice. Oncotarget, 7 (36), 58405–58417.
  • Pickart, L., Thaler, M.M., and Millard, M., 1979. Effect of transition metals on recovery from plasma of the growth-modulating tripeptide glycylhistidyllysine. Journal of chromatography, 175 (1), 65–73.
  • Pickart, L., Vasquez-Soltero, J.M., and Margolina, A., 2012. The human tripeptide GHK-Cu in prevention of oxidative stress and degenerative conditions of aging: implications for cognitive health. Oxidative medicine and cellular longevity, 2012, 324832.
  • Pickart, L., Vasquez-Soltero, J.M., and Margolina, A., 2015a. GHK-Cu may prevent oxidative stress in skin by regulating copper and modifying expression of numerous antioxidant genes. Cosmetics, 2 (3), 236–247.
  • Pickart, L., Vasquez-Soltero, J.M., and Margolina, A., 2015b. GHK peptide as a natural modulator of multiple cellular pathways in skin regeneration. BioMed research international, 2015, 1–7.
  • Qin, L., et al., 2014. A dual-targeting liposome conjugated with transferrin and arginine-glycine-aspartic acid peptide for glioma-targeting therapy. Oncology letters, 8 (5), 2000–2006.
  • Rabenstein, D.L., Robert, J.M., and Hari, S., 1995. Binding of the growth factor glycyl-L-histidyl-L-lysine by heparin. FEBS letters, 376 (3), 216–220.
  • Rakhmatullina, E., and Meier, W., 2008. Solid-supported block copolymer membranes through interfacial adsorption of charged block copolymer vesicles. Langmuir, 24 (12), 6254–6261.
  • Reungpatthanaphong, P., et al., 2003. Rhodamine B as a mitochondrial probe for measurement and monitoring of mitochondrial membrane potential in drug-sensitive and -resistant cells. Journal of biochemical and biophysical methods, 57 (1), 1–16.
  • Ropartz, D., and Ralet, M.-C., 2020. Pectin structure. In: V. Kontogiorgos, ed. Pectin: technological and physiological properties. Cham: Springer International Publishing.
  • Sakuma, S., et al., 2018. The peptide glycyl-L-histidyl-L-lysine is an endogenous antioxidant in living organisms, possibly by diminishing hydroxyl and peroxyl radicals. International journal of physiology, pathophysiology and pharmacology, 10, 132–138.
  • Sarelius, I.H., et al., 2016. Extracellular matrix fibronectin initiates endothelium-dependent arteriolar dilatation via the heparin-binding, matricryptic RWRPK sequence of the first type III repeat of fibrillar fibronectin. The journal of physiology, 594 (3), 687–697.
  • Srivastava, V. K., and Yadav, R., 2019. Chapter 9 – Isothermal titration calorimetry. In: G. Misra, ed. Data processing handbook for complex biological data sources. London: Academic Press.
  • Takechi-Haraya, Y., et al., 2016. Atomic force microscopic analysis of the effect of lipid composition on liposome membrane rigidity. Langmuir, 32 (24), 6074–6082.
  • Tomori, Y., et al., 2018. Morphological analysis of trafficking and processing of anionic and cationic liposomes in cultured cells. Acta histochemica et cytochemica, 51 (2), 81–92.
  • Visser, R., et al., 2016. Peptides for bone tissue engineering. Journal of controlled release, 244 (Pt A), 122–135.
  • Vlieghe, P., et al., 2010. Synthetic therapeutic peptides: science and market. Drug discovery today, 15 (1–2), 40–56.
  • Wang, J., Zhu, M., and Nie, G., 2021. Biomembrane-based nanostructures for cancer targeting and therapy: from synthetic liposomes to natural biomembranes and membrane-vesicles. Advanced drug delivery reviews, 178, 113974.
  • Wang, X., et al., 2017. GHK-Cu-liposomes accelerate scald wound healing in mice by promoting cell proliferation and angiogenesis. Wound repair and regeneration, 25 (2), 270–278.
  • Wijelath, E.S., et al., 2006. Heparin-ii domain of fibronectin is a vascular endothelial growth factor-binding domain. Circulation research, 99 (8), 853–860.
  • Yang, F., Jin, S., and Tang, Y., 2019. Marine collagen peptides promote cell proliferation of NIH-3T3 fibroblasts via NF-κB signaling pathway. Molecules, 24 (22), 4201.
  • Yang, Y., et al., 2015. Dual-modified liposomes with a two-photon-sensitive cell penetrating peptide and NGR ligand for siRNA targeting delivery. Biomaterials, 48, 84–96.
  • Zhou, X.M., et al., 2017. GHK peptide inhibits bleomycin-induced pulmonary fibrosis in mice by suppressing TGFbeta1/Smad-mediated epithelial-to-mesenchymal transition. Frontiers in pharmacology, 8, 904.
  • Zoughaib, M., et al., 2021a. Enhanced angiogenic effects of RGD, GHK peptides and copper (II) compositions in synthetic cryogel ECM model. Materials science & engineering C, 120, 111660.
  • Zoughaib, M., et al., 2021b. Amphiphilic RGD and GHK peptides synergistically enhance liposomal delivery into cancer and endothelial cells. Materials advances, 2 (23), 7715–7730.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.